Duty free import/domestic procurement of goods for development, operation and maintenance of SEZ units.
Exemption from central sales tax.
Exemption from service tax.
Exemption from state sales tax and other levies as extended by the respective State Governments.
US FQ 29:
(on US 84)
Report by the Secretariat (WT/TPR/S/249): III. TRADE POLICIES AND PRACTICES BY MEASURE: (3) Measures Directly Affecting Exports: (4) Measures Affecting Production and Trade: (vi) Intellectual property rights: Page 114, paragraph 250
The Secretariat discusses the proof of efficacy requirement in Section 3(d) of India's Patent Act. Under Section 3(d), if an applicant demonstrates the novelty, non-obviousness, and industrial use of a product, can it still be denied a patent on the grounds that it fails to also demonstrate a significant improvement in efficacy? Does the Government of India consider this requirement to be in line with TRIPS Article 27(1) which states that patents shall be available for inventions in all fields of technology provided they are new, involve an inventive step, and are capable of industrial application? Please explain.
